Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coagulotoxic Cobras: Clinical Implications of Strong Anticoagulant Actions of African Spitting Naja Venoms That Are Not Neutralised by Antivenom but Are by LY315920 (Varespladib)
Mátyás A. Bittenbinder, Christina N. Zdenek, Bianca op den Brouw, et al.
Toxins (2018) Vol. 10, Iss. 12, pp. 516-516
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving
Tarek Mohamed Abd El‐Aziz, António G. Soares, James D. Stockand
Toxins (2019) Vol. 11, Iss. 10, pp. 564-564
Open Access | Times Cited: 185
Beyond the ‘big four’: Venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies
R. R. Senji Laxme, Suyog Khochare, Hugo Francisco de Souza, et al.
PLoS neglected tropical diseases (2019) Vol. 13, Iss. 12, pp. e0007899-e0007899
Open Access | Times Cited: 155
Tissue damaging toxins in snake venoms: mechanisms of action, pathophysiology and treatment strategies
Mátyás A. Bittenbinder, Jory van Thiel, Fernanda C. Cardoso, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 41
The Urgent Need to Develop Novel Strategies for the Diagnosis and Treatment of Snakebites
Harry F. Williams, Harry J. Layfield, Thomas M. Vallance, et al.
Toxins (2019) Vol. 11, Iss. 6, pp. 363-363
Open Access | Times Cited: 110
Snakebite: When the Human Touch Becomes a Bad Touch
Bryan G. Fry
Toxins (2018) Vol. 10, Iss. 4, pp. 170-170
Open Access | Times Cited: 93
Biogeographical venom variation in the Indian spectacled cobra (Naja naja) underscores the pressing need for pan-India efficacious snakebite therapy
R. R. Senji Laxme, Saurabh Attarde, Suyog Khochare, et al.
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 2, pp. e0009150-e0009150
Open Access | Times Cited: 75
Varespladib (LY315920) and Methyl Varespladib (LY333013) Abrogate or Delay Lethality Induced by Presynaptically Acting Neurotoxic Snake Venoms
José Marı́a Gutiérrez, Matthew R. Lewin, David J. Williams, et al.
Toxins (2020) Vol. 12, Iss. 2, pp. 131-131
Open Access | Times Cited: 74
Varespladib in the Treatment of Snakebite Envenoming: Development History and Preclinical Evidence Supporting Advancement to Clinical Trials in Patients Bitten by Venomous Snakes
Matthew R. Lewin, Rebecca W. Carter, Isabel A. Matteo, et al.
Toxins (2022) Vol. 14, Iss. 11, pp. 783-783
Open Access | Times Cited: 47
Amplification of Snake Venom Toxicity by Endogenous Signaling Pathways
Philip E. Bickler
Toxins (2020) Vol. 12, Iss. 2, pp. 68-68
Open Access | Times Cited: 68
Snake antivenom: Challenges and alternate approaches
Aswathy Alangode, Karthika Rajan, Bipin G. Nair
Biochemical Pharmacology (2020) Vol. 181, pp. 114135-114135
Closed Access | Times Cited: 54
Varespladib Inhibits the Phospholipase A2 and Coagulopathic Activities of Venom Components from Hemotoxic Snakes
Chunfang Xie, Laura-Oana Albulescu, Kristina B. M. Still, et al.
Biomedicines (2020) Vol. 8, Iss. 6, pp. 165-165
Open Access | Times Cited: 51
Small Molecule Drug Discovery for Neglected Tropical Snakebite
Rachel H. Clare, Steven R. Hall, Rohit N. Patel, et al.
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 5, pp. 340-353
Open Access | Times Cited: 50
Clinical management of snakebite envenoming: Future perspectives
Muhammad Hamza, Cecilie Knudsen, Christeine Ariaranee Gnanathasan, et al.
Toxicon X (2021) Vol. 11, pp. 100079-100079
Open Access | Times Cited: 48
The BRAVO Clinical Study Protocol: Oral Varespladib for Inhibition of Secretory Phospholipase A2 in the Treatment of Snakebite Envenoming
Rebecca W. Carter, Charles J. Gerardo, Stephen P. Samuel, et al.
Toxins (2022) Vol. 15, Iss. 1, pp. 22-22
Open Access | Times Cited: 30
Neutralizing Effects of Small Molecule Inhibitors and Metal Chelators on Coagulopathic Viperinae Snake Venom Toxins
Chunfang Xie, Laura-Oana Albulescu, Mátyás A. Bittenbinder, et al.
Biomedicines (2020) Vol. 8, Iss. 9, pp. 297-297
Open Access | Times Cited: 43
An Appetite for Destruction: Detecting Prey-Selective Binding of α-Neurotoxins in the Venom of Afro-Asian Elapids
Richard J. Harris, Christina N. Zdenek, David Harrich, et al.
Toxins (2020) Vol. 12, Iss. 3, pp. 205-205
Open Access | Times Cited: 42
Promoting co-existence between humans and venomous snakes through increasing the herpetological knowledge base
Anita Malhotra, Wolfgang Wüster, John Benjamin Owens, et al.
Toxicon X (2021) Vol. 12, pp. 100081-100081
Open Access | Times Cited: 37
Remarkable intrapopulation venom variability in the monocellate cobra (Naja kaouthia) unveils neglected aspects of India's snakebite problem
U. Rashmi, Suyog Khochare, Saurabh Attarde, et al.
Journal of Proteomics (2021) Vol. 242, pp. 104256-104256
Closed Access | Times Cited: 33
Unraveling snake venom phospholipase A2: an overview of its structure, pharmacology, and inhibitors
Ganesh H. Sampat, Kashinath Hiremath, Jagadeesh Dodakallanavar, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1454-1473
Closed Access | Times Cited: 14
Ruthenium-based antivenom attenuates Crotalus atrox venom mediated coagulopathy in rabbits
Vance G. Nielsen
Blood Coagulation & Fibrinolysis (2024) Vol. 35, Iss. 4, pp. 167-172
Closed Access | Times Cited: 5
PLA2 Inhibitor Varespladib as an Alternative to the Antivenom Treatment for Bites from Nikolsky’s Viper Vipera berus nikolskii
Олександр Зіненко, Igor Tovstukha, Yevgen Korniyenko
Toxins (2020) Vol. 12, Iss. 6, pp. 356-356
Open Access | Times Cited: 38
Varespladib (LY315920) neutralises phospholipase A2 mediated prothrombinase-inhibition induced by Bitis snake venoms
Nicholas J. Youngman, Andrew A. Walker, Arno Naude, et al.
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2020) Vol. 236, pp. 108818-108818
Closed Access | Times Cited: 37
In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus
Stefanie K. Menzies, Rachel H. Clare, Chunfang Xie, et al.
Toxicon X (2022) Vol. 14, pp. 100118-100118
Open Access | Times Cited: 21
In Vitro Efficacy of Antivenom and Varespladib in Neutralising Chinese Russell’s Viper (Daboia siamensis) Venom Toxicity
Mimi Lay, Qing Liang, Geoffrey K. Isbister, et al.
Toxins (2023) Vol. 15, Iss. 1, pp. 62-62
Open Access | Times Cited: 12
The Clot Thickens: Differential Coagulotoxic and Cardiotoxic Activities of Anguimorpha Lizard Venoms
James Dobson, Abhinandan Chowdhury, Jeremie Tai-A-Pin, et al.
Toxins (2024) Vol. 16, Iss. 6, pp. 283-283
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top